136 results on '"Carlsten, Hans"'
Search Results
2. Role of estrogen signaling in fibroblastic reticular cells for innate and adaptive immune responses in antigen‐induced arthritis.
3. Local Immune Activation and Age Impact on Humoral Immunity in Mice, with a Focus on IgG Sialylation.
4. Effects of a tissue-selective estrogen complex on B lymphopoiesis and B cell function
5. Ovarian hormones in innate inflammation
6. A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin
7. IL-17-producing γδT cells are regulated by estrogen during development of experimental arthritis
8. Impact of estrogen on IgG glycosylation and serum protein glycosylation in a murine model of healthy postmenopause.
9. Selective estrogen receptor modulators in T cell development and T cell dependent inflammation
10. The estrogen receptor antagonist ICI 182,780 can act both as an agonist and an inverse agonist when estrogen receptor α AF-2 is modified
11. Bazedoxifene does not share estrogens effects on IgG sialylation.
12. A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis
13. Methotrexate inhibits effects of platelet-derived growth factor and interleukin-1β on rheumatoid arthritis fibroblast-like synoviocytes
14. Sexual dimorphisms in the immune system of catechol-O-methyltransferase knockout mice
15. Estrogen receptor-α expression in neuronal cells affects bone mass
16. Ethanol Prevents Development of Destructive Arthritis
17. Rapid Systemic Bone Resorption during the Course of Staphylococcus aureus-Induced Arthritis
18. Selective oestrogen receptor modulators lasofoxifene and bazedoxifene inhibit joint inflammation and osteoporosis in ovariectomised mice with collagen-induced arthritis
19. Reduction of Mature B Cells and Immunoglobulins Results in Increased Trabecular Bone.
20. ERα Signaling in a Subset of CXCL12‐Abundant Reticular Cells Regulates Trabecular Bone in Mice.
21. Periarticular Bone Loss in Antigen-Induced Arthritis
22. A tissue-selective estrogen complex as treatment of osteoporosis in experimental lupus.
23. Interleukin-6-deficient mice develop mature-onset obesity
24. Amelioration of collagen-induced arthritis and immune-associated bone loss through signaling via estrogen receptor α, and not estrogen receptor β or G protein–coupled receptor 30
25. The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial
26. Low Serum Levels of Sex Steroids Are Associated with Disease Characteristics in Primary Sjogren’s Syndrome; Supplementation with Dehydroepiandrosterone Restores the Concentrations
27. Role of Raloxifene As A Potent inhibitor of Experimental Postmenopausal Polyarthritis and Osteoporosis
28. Immune responses and bone loss: the estrogen connection
29. The impact of a new immunomodulator oxo-quinoline-3-carboxamide on the progression of experimental lupus
30. Mycophenolic acid inhibits inosine 5′-monophosphate dehydrogenase and suppresses immunoglobulin and cytokine production of B cells
31. Role of oestrogen receptors α and β in immune organ development and in oestrogen-mediated effects on thymus
32. Immunoglobulin G complexes without sialic acids enhance osteoclastogenesis but do not affect arthritis‐mediated bone loss.
33. Bone mineral density by digital X-ray radiogrammetry is strongly decreased and associated with joint destruction in long-standing Rheumatoid Arthritis: a cross-sectional study
34. Hormone replacement therapy, calcium and vitamin D3 versus calcium and vitamin D3alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456]
35. Role of endogenous and exogenous female sex hormones in arthritis and osteoporosis development in B10.Q-ncf1*/* mice with collagen-induced chronic arthritis
36. Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1
37. Elevated serum level of hepatocyte growth factor predicts development of new syndesmophytes in men with ankylosing spondylitis.
38. Intermediate monocytes correlate with CXCR3+ Th17 cells but not with bone characteristics in untreated early rheumatoid arthritis.
39. Estren promotes androgen phenotypes in primary lymphoid organs and submandibular glands
40. Androgen Receptors in Epithelial Cells Regulate Thymopoiesis and Recent Thymic Emigrants in Male Mice.
41. The Rheumatoid Arthritis Risk Gene AIRE Is Induced by Cytokines in Fibroblast-Like Synoviocytes and Augments the Pro-inflammatory Response.
42. Testosterone Protects Against Atherosclerosis in Male Mice by Targeting Thymic Epithelial Cells—Brief Report.
43. Testosterone is an endogenous regulator of BAFF and splenic B cell number.
44. Age‐associated B cells expanded in autoimmune mice are memory cells sharing H‐CDR3‐selected repertoires.
45. Roles of activating functions 1 and 2 of estrogen receptor α in lymphopoiesis.
46. Which measuring site in ankylosing spondylitis is best to detect bone loss and what predicts the decline: results from a 5-year prospective study.
47. A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis.
48. Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss.
49. SERMs have substance-specific effects on bone, and these effects are mediated via ERαAF-1 in female mice.
50. Trabecular bone loss in collagen antibody-induced arthritis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.